Safe Financial Buffer in Clinical Trials: Learn the Recommendations from CRO Experts

Safe Financial Buffer in Clinical Trials: Learn the Recommendations from CRO Experts

Planning the budget for a clinical or non-interventional trial is a process that requires precision, experience, and a realistic risk assessment. While sponsors often focus on direct costs—visits, procedures, site compensation, and project management—practice shows that unforeseen expenses are the most common cause of delays, schedule changes, or the need to renegotiate the budget. This is why a financial buffer, already included in the planning stage, is one of the key elements of a well-managed study.

CRO experts recommend that, in the early stages of the project, a buffer of 10–30% of the total budget should be planned, depending on the complexity of the protocol, the number of sites, and the study population. Lower values are effective in short-term and well-standardized studies, while in multi-center projects, with new technologies or high operational risk, a buffer closer to the upper limit is safer.

The budget reserve covers areas such as: additional patient visits, equipment orders, higher-than-expected shipping costs, increased number of monitoring visits, the need to expand CRO activities, adjusting eCRF/eTMF, training new personnel at the site, recruitment extension, or unplanned medical actions related to participant safety. In practice, these categories account for most of the financial deviations in clinical projects.

Including a buffer at the outset does not mean increasing costs—it means controlling them. The reserve allows the study to be conducted without compromising quality, while also protecting sponsors from the need for sudden payments at crucial points in the project. This is especially important in light of increasing regulatory demands and pressure for timely delivery of results.

If you want to ensure that your study's budget is realistically planned and includes an appropriate financial buffer, schedule a free consultation with our CRO experts. Our experienced team will help assess risks, verify assumptions, and prepare a budget resilient to unexpected challenges.

Other questions: Budget and research financing

Articles

New Knowledge Base on Clinical Trials New Knowledge Base on Clinical Trials
  For several years now, the Biostat Research and Development Center has operated as a Full-Service CRO – an organization providing comprehensive support...
Voice Assistant for Doctors – A New AI Feature in the Medfile Program Voice Assistant for Doctors – A New AI Feature in the Medfile Program
Biostat's developers are launching a Voice Assistant for doctors in the Medfile software designed for medical facilities. This AI-based tool operates in ...
Clinical Trial of an Innovative Intramedullary Nail Clinical Trial of an Innovative Intramedullary Nail
The Biostat Research and Development Center will conduct a multicenter, open-label clinical trial aimed at evaluating the safety and efficacy of the Orthoget...
Copyright© 2023 Biostat